Systemic treatment with sympatholytic dopamine agonists improves aberrant [beta ]-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice
Keyword(s):
2010 ◽
Vol 16
(14)
◽
pp. 1550-1560
◽
2000 ◽
Vol 3
(1)
◽
pp. 48-52
◽
Keyword(s):
Keyword(s):
1992 ◽
Vol 50
(1)
◽
pp. 53-57
◽